Abstract
Immune chronic active hepatitis is a disease notorious for its unpredictability. In a patient with chronic hepatitis who has already suffered relapses a search for a second cause of jaundice is not usually necessary. This report emphasises the essential role of liver biopsy.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- García Rodríguez L. A., Pérez Gutthann S., Walker A. M., Lueck L. The role of non-steroidal anti-inflammatory drugs in acute liver injury. BMJ. 1992 Oct 10;305(6858):865–868. doi: 10.1136/bmj.305.6858.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Michel G., Ritter A., Gerken G., Meyer zum Büschenfelde K. H., Decker R., Manns M. P. Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet. 1992 Feb 1;339(8788):267–269. doi: 10.1016/0140-6736(92)91332-3. [DOI] [PubMed] [Google Scholar]
- Murray-Lyon I. M., Stern R. B., Williams R. Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet. 1973 Apr 7;1(7806):735–737. doi: 10.1016/s0140-6736(73)92125-9. [DOI] [PubMed] [Google Scholar]
- Soloway R. D., Summerskill W. H., Baggenstoss A. H., Geall M. G., Gitnićk G. L., Elveback I. R., Schoenfield L. J. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972 Nov;63(5):820–833. [PubMed] [Google Scholar]
- Warren J. S. Diflunisal-induced cholestatic jaundice. Br Med J. 1978 Sep 9;2(6139):736–737. doi: 10.1136/bmj.2.6139.736. [DOI] [PMC free article] [PubMed] [Google Scholar]